This article is freely available to all

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We have recently observed 2 cases of acute dystonic reactions in ziprasidone-treated patients with bipolar disorder. Although characterized by relatively high dopamine-2 (D2) binding, ziprasidone has been associated with a low rate of extrapyramidal symptoms and dystonia.1,2 Of 4 early clinical trials with ziprasidone,3-6 only 1 trial, in patients with schizophrenia and schizoaffective disorder, has reported any dystonia.3